The Scripps Molecular Screening Center and Translational Research Institute
暂无分享,去创建一个
Louis Scampavia | Timothy P. Spicer | Hugh Rosen | Patrick R. Griffin | Pierre Baillargeon | Virneliz Fernandez-Vega | Banu Priya Sridharan | Steven Brown | Benjamin Cravatt | Steven J Brown | T. Spicer | P. Griffin | B. Cravatt | H. Rosen | L. Scampavia | V. Fernández-Vega | Pierre Baillargeon | BanuPriya Sridharan
[1] Louis Scampavia,et al. An Integrated Approach for Screening and Identification of Positive Allosteric Modulators of N-Methyl-D-Aspartate Receptors , 2016, Journal of biomolecular screening.
[2] Louis Scampavia,et al. A 1536-Well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids , 2017, SLAS discovery : advancing life sciences R & D.
[3] Peter Hodder,et al. Monitoring of HTS Compound Library Quality via a High-Resolution Image Acquisition and Processing Instrument , 2011, Journal of laboratory automation.
[4] J. Baell. Observations on screening-based research and some concerning trends in the literature. , 2010, Future medicinal chemistry.
[5] Payal Rana,et al. Utilization of iPSC-derived human neurons for high-throughput drug-induced peripheral neuropathy screening. , 2017, Toxicology in vitro : an international journal published in association with BIBRA.
[6] Louis Scampavia,et al. A Novel 3-dimensional High Throughput Screening Approach Identifies Inducers of a Mutant KRAS Selective Lethal Phenotype , 2018, Oncogene.
[7] Peter Hodder,et al. Improved Scalability of Neuron-Based Phenotypic Screening Assays for Therapeutic Discovery in Neuropsychiatric Disorders , 2017, Molecular Neuropsychiatry.
[8] Jiri Bartek,et al. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adapter NPL4 , 2017, Nature.
[9] Louis Scampavia,et al. IoT for Real-Time Measurement of High-Throughput Liquid Dispensing in Laboratory Environments , 2018, SLAS technology.
[10] J. Baell,et al. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.
[11] M. Bickle. The Academic Pill: How Academia Contributes to Curing Diseases , 2019, SLAS discovery : advancing life sciences R & D.
[12] Louis Scampavia,et al. A Homogeneous Cell-Based Halide-Sensitive Yellow Fluorescence Protein Assay to Identify Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Ion Channel. , 2017, Assay and drug development technologies.
[13] Tudor I. Oprea,et al. Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes , 2015, Cell.
[14] Dirk Schumacher,et al. Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures , 2016, Journal of biomolecular screening.
[15] Louis Scampavia,et al. Drug Library Screening for the Identification of Ionophores That Correct the Mistrafficking Disorder Associated with Oxalosis Kidney Disease , 2017, SLAS discovery : advancing life sciences R & D.
[16] Louis Scampavia,et al. Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening , 2018, SLAS discovery : advancing life sciences R & D.
[17] R H Hruban,et al. Progression model for pancreatic cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] Dmitriy Minond,et al. Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker. , 2013, Bioorganic & medicinal chemistry.